DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth Knowing

Company Performance - DaVita HealthCare (DVA) shares experienced a loss of 2.97% over the previous month, underperforming the Medical sector's loss of 1.99% and the S&P 500's gain of 4.34% [1] - In the latest trading session, DaVita HealthCare closed at $137.92, reflecting a +0.39% move from the prior day, outperforming the S&P 500's daily gain of 0.07% [6] - The upcoming earnings disclosure is projected to show earnings of $2.47 per share, indicating year-over-year growth of 18.75%, with a revenue estimate of $3.16 billion, representing a 5.43% rise from the same quarter last year [7] Financial Estimates - For the entire fiscal year, earnings are projected at $9.62 per share and revenue at $12.74 billion, reflecting changes of +13.58% and +4.97% from the prior year, respectively [2] - DaVita HealthCare currently has a Forward P/E ratio of 14.27, which is below the industry average Forward P/E of 22.5, indicating it is trading at a discount compared to its peers [9] Analyst Insights - Recent changes to analyst estimates for DaVita HealthCare are important as they reflect short-term business trends, with positive revisions indicating analysts' confidence in the company's performance [8] - The Zacks Rank system rates DaVita HealthCare at 2 (Buy), with a track record of delivering an average annual return of +25% for stocks rated 1 since 1988 [11] Industry Context - The Medical - Outpatient and Home Healthcare industry, which includes DaVita HealthCare, has a current Zacks Industry Rank of 52, placing it in the top 21% of over 250 industries [12]